Embecta Releases Q2 Fiscal 2026 Results
The company underscores a shift from insulin delivery toward a broader medical supplies portfolio.
Overview
- Embecta, which reported second quarter results Tuesday, directed investors to its website for the full release and presentation.
- The company held a live call and webcast at 8:00 a.m. ET, with a replay posted at 11:00 a.m. ET on its investor site.
- Management described Embecta as moving from a 100-year insulin delivery legacy to a broad medical supplies focus.
- The firm employs about 2,000 people worldwide and trades on Nasdaq under the ticker EMBC.
- Media and investor contacts listed in the release include Christian Glazar for communications and Pravesh Khandelwal for investor relations.